Cronos Group Inc. (CRON)
CRON Stock Price Chart
Explore Cronos Group Inc. interactive price chart. Choose custom timeframes to analyze CRON price movements and trends.
CRON Company Profile
Discover essential business fundamentals and corporate details for Cronos Group Inc. (CRON) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
27 Feb 2018
Employees
459.00
Website
https://www.thecronosgroup.comCEO
Michael Ryan Gorenstein
Description
Cronos Group Inc. is a company primarily focused on cannabinoids. In the United States, it develops, promotes, and supplies hemp-derived wellness and beauty products under the Lord Jones and Happy Dance brands, reaching consumers through online sales, traditional retail outlets, and partnerships within the hospitality sector. Beyond hemp, the company also engages in the cultivation, production, and commercialization of cannabis and its related extracts for both therapeutic and recreational consumption. Its cannabis offerings encompass dried flower, pre-rolled joints, edibles, concentrates, and various extracts, which are distributed via wholesale channels and directly to clients. The wellness segment operates under the PEACE NATURALS platform, while its adult-use products are marketed through the Spinach brand. Additionally, Cronos exports dried cannabis and cannabis oils to international markets such as Germany, Israel, and Australia. Founded in 2012, the company's headquarters are located in Toronto, Canada.
CRON Financial Timeline
Browse a chronological timeline of Cronos Group Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is $0.01, while revenue estimate is $44.20m.
Earnings released on 11 May 2026
EPS came in at $0.01 matching the estimated $0.01, while revenue for the quarter reached $45.21m , beating expectations by +7.13%.
Earnings released on 26 Feb 2026
EPS came in at -$0.00 falling short of the estimated $0.01 by -147.00%, while revenue for the quarter reached $44.53m , beating expectations by +15.01%.
Earnings released on 6 Nov 2025
EPS came in at $0.07 surpassing the estimated $0.02 by +250.00%, while revenue for the quarter reached $36.34m , missing expectations by -5.45%.
Earnings released on 7 Aug 2025
EPS came in at -$0.10 falling short of the estimated -$0.02 by -400.00%, while revenue for the quarter reached $32.36m , missing expectations by -13.34%.
Earnings released on 8 May 2025
EPS came in at $0.02 surpassing the estimated -$0.01 by +378.55%, while revenue for the quarter reached $22.65m , missing expectations by -28.44%.
Earnings released on 27 Feb 2025
EPS came in at -$0.01 matching the estimated -$0.01, while revenue for the quarter reached $21.06m , missing expectations by -37.47%.
Earnings released on 12 Nov 2024
EPS came in at -$0.02 falling short of the estimated -$0.01 by -300.00%, while revenue for the quarter reached $25.25m , missing expectations by -26.91%.
Earnings released on 8 Aug 2024
EPS came in at -$0.02 falling short of the estimated -$0.00 by -700.00%, while revenue for the quarter reached $20.30m , beating expectations by +6.75%.
Earnings released on 9 May 2024
EPS came in at -$0.01 falling short of the estimated -$0.01 by -25.00%, while revenue for the quarter reached $18.54m , beating expectations by +6.58%.
Earnings released on 29 Feb 2024
EPS came in at -$0.05 falling short of the estimated -$0.02 by -233.33%, while revenue for the quarter reached $18.50m , missing expectations by -2.02%.
Earnings released on 8 Nov 2023
EPS came in at -$0.00 falling short of the estimated -$0.00 by -100.00%, while revenue for the quarter reached $18.32m , missing expectations by -1.06%.
Earnings released on 8 Aug 2023
EPS came in at -$0.02 falling short of the estimated -$0.01 by -68.78%, while revenue for the quarter reached $14.36m , missing expectations by -15.11%.
Earnings released on 9 May 2023
EPS came in at -$0.03 surpassing the estimated -$0.04 by +25.00%, while revenue for the quarter reached $14.89m , missing expectations by -17.10%.
Earnings released on 28 Feb 2023
EPS came in at -$0.14 falling short of the estimated -$0.05 by -180.00%, while revenue for the quarter reached $17.06m , missing expectations by -23.17%.
Earnings released on 7 Nov 2022
EPS came in at -$0.07 falling short of the estimated -$0.06 by -16.67%, while revenue for the quarter reached $15.28m , missing expectations by -38.87%.
Earnings released on 9 Aug 2022
EPS came in at -$0.05 matching the estimated -$0.05, while revenue for the quarter reached $17.90m , missing expectations by -36.04%.
Earnings released on 10 May 2022
EPS came in at -$0.09 falling short of the estimated -$0.08 by -12.50%, while revenue for the quarter reached $20.02m , missing expectations by -16.48%.
Earnings released on 1 Mar 2022
EPS came in at -$0.36 falling short of the estimated -$0.10 by -260.00%, while revenue for the quarter reached $20.23m , missing expectations by -14.21%.
Earnings released on 18 Feb 2022
EPS came in at $0.16 , while revenue for the quarter reached $16.10m .
Earnings released on 6 Aug 2021
EPS came in at -$0.09 falling short of the estimated -$0.07 by -28.57%, while revenue for the quarter reached $12.60m , beating expectations by +12.95%.
CRON Stock Performance
Access detailed CRON performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
